Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-20-001477
Filing Date
2020-02-14
Accepted
2020-02-14 16:00:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 r24201sc13g.htm SC 13G 43829
2 GRAPHIC jdrillick_sig.jpg GRAPHIC 3335
  Complete submission text file 0001214659-20-001477.txt   50041
Mailing Address 535 FIFTH AVENUE SUITE 910 NEW YORK NY 10017
Business Address 535 FIFTH AVENUE SUITE 910 NEW YORK NY 10017 212-601-9786
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 20619101
SIC: 2834 Pharmaceutical Preparations